Which regulatory body outlines MTM services?

The Centers for Medicare and Medicaid Services (CMS) is the regulatory body responsible for outlining Medication Therapy Management (MTM) services. CMS plays a critical role in establishing the guidelines and requirements for MTM programs, especially as they pertain to Medicare Part D plans. These guidelines aim to ensure that beneficiaries receive comprehensive medication reviews, develop medication action plans, and achieve better therapeutic outcomes. By delineating the framework within which MTM services must operate, CMS addresses issues of safety, efficacy, and cost-effectiveness in medication management, making it essential for pharmacy practice and patient care.

The other organizations listed have distinct roles unrelated to MTM services; for instance, the FDA primarily regulates the approval and safety of drugs, the CDC focuses on public health and disease prevention, and the NIH conducts medical research. Hence, the appropriate regulatory oversight specifically for MTM services falls under CMS.